Compass Therapeutics to Participate in Upcoming Investor Events
01 Juni 2023 - 4:06PM
Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage,
oncology-focused biopharmaceutical company developing proprietary
antibody-based therapeutics to treat multiple human diseases, today
announced that the Company will participate in the following
investor events during the month of June 2023.
Details are as follows:
Jefferies Global Healthcare
Conference Location: New York,
NYFormat: Presentation Date:
Thursday, June 8Time: 2-2:25 PM ET Webcast
Link: https://wsw.com/webcast/jeff281/cmpx/1864720
World Medical Innovation Forum hosted by
Mass General Brigham Innovation and Bank of America
Location: Boston, MA Format:
Panel: The Disruptors: The Biologic Revolution in Cancer
ContinuesDate: Tuesday, June
13Time: 8:30-9:30 AM ET
Virtual/Replay
availability: Presentations will be archived for 90
days on Compass’ Events page.
About Compass TherapeuticsCompass Therapeutics,
Inc. is a clinical-stage oncology-focused biopharmaceutical company
developing proprietary antibody-based therapeutics to treat
multiple human diseases. Compass’s scientific focus is on the
relationship between angiogenesis, the immune system, and tumor
growth. The company pipeline of novel product candidates is
designed to target multiple critical biological pathways required
for an effective anti-tumor response. These include modulation of
the microvasculature via angiogenesis-targeted agents, induction of
a potent immune response via activators on effector cells in the
tumor microenvironment, and alleviation of immunosuppressive
mechanisms used by tumors to evade immune surveillance. Compass
plans to advance its product candidates through clinical
development as both standalone therapies and in combination with
proprietary pipeline antibodies based on supportive clinical and
nonclinical data. The company was founded in 2014 and is
headquartered in Boston, Massachusetts. For more information, visit
the Compass Therapeutics website
at https://www.compasstherapeutics.com.
Investor Contactir@compasstherapeutics.com
Media ContactAnna Gifford, Communications
Managermedia@compasstherapeutics.com 617-500-8099
Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024